Copyright
©The Author(s) 2021.
World J Gastrointest Surg. Sep 27, 2021; 13(9): 1102-1109
Published online Sep 27, 2021. doi: 10.4240/wjgs.v13.i9.1102
Published online Sep 27, 2021. doi: 10.4240/wjgs.v13.i9.1102
Recipient | Donor | |
Age | 64 | 12 |
Sex | Female | Male |
Primary complaint | PBC | Hypoxic-ischemic encephalopathy |
Special history | Low-dose glucocorticoids | NA |
Blood group | A | A |
HLA | NA | NA |
Manifestations | Drugs | ||||||||
PO day | Temperature (°C) | Skin rash | Diarrhea | Myelosuppression | Tacrolimus (mg/d) | MMF (g/d) | MP | IgG (g/d) | Antibiotics |
22 | 38.3 | Palm | 2 | NA | 3 | 0.25 | 500 | 10 | Yes |
24 | 38.6 | Neck | 3 | NA | 2 | 0 | 500 | 10 | Yes |
26 | 38.5 | Face | 6 | Yes | 2 | 0 | 120 | NA | Yes |
28 | 38.2 | Trunk | 7 | Yes | 2 | 0 | 40 | NA | Yes |
30 | 39 | > 35% | 6 | Yes | 2 | 0 | 20 | NA | Yes |
32 | 38.6 | > 50% | 5 | Yes | 1.5 | 0 | 20 | 10 | Yes |
34 | 38.7 | > 55% | 4 | Yes | 1.5 | 0 | 20 | 10 | NA |
36 | Demise |
Post-operative laboratory investigation timeline | |||||||||||
Value/PO day | 0 | 4 | 8 | 12 | 16 | 20 | 24 | 26 | 30 | 34 | 36 |
AST (U/L) | 643 | 47.6 | 56 | 48 | 64 | 75 | 63 | 56 | 44 | 52 | 74 |
ALT (U/L) | 772 | 88.1 | 96 | 86 | 107.3 | 62 | 59 | 64 | 66 | 71 | 83 |
Total bilirubin (mg/dL) | 231.4 | 123.5 | 119.5 | 76.9 | 65.5 | 23.7 | 25.8 | 24.2 | 35.1 | 45.6 | 48.7 |
Direct bilirubin (mg/dL) | 146.1 | 63.2 | 59.3 | 43.2 | 38.1 | 13.3 | 15.6 | 16.5 | 24.7 | 28.5 | 31.2 |
Leukocyte count × 109/L | 17.5 | 8.7 | 12.4 | 17.3 | 7.2 | 6.7 | 1.3 | 0.39 | 0.24 | 0.12 | 0.08 |
Neutrophil % | 93 | 79 | 86 | 92 | 81 | 80 | 63 | 17.9 | 0 | 0 | 0 |
Hemoglobin (g/L) | 89 | 92 | 176 | 113 | 92 | 85 | 75 | 63 | 58 | 53 | 47 |
Hematocrit % | 42 | 46 | 50 | 32 | 26.5 | 23.3 | 22 | 17.6 | 16.5 | 15.6 | 14.8 |
Platelets × 109/L | 21 | 26 | 44 | 58 | 77 | 73 | 71 | 56 | 47 | 46 | 41 |
Prothrombin time (s) | 17.9 | 19.9 | 16.5 | 22.4 | 13.5 | 13.1 | 12.7 | 13.1 | 12.8 | 13.2 | 13.6 |
INR | 1.82 | 1.7 | 1.34 | 1.98 | 1.05 | 1.01 | 0.97 | 0.99 | 0.98 | 1.02 | 1.07 |
Sodium (mmol/L) | 147 | 145 | 142 | 139 | 136 | 134 | 143 | 141 | 138 | 139 | 143 |
Potassium (mmol/L) | 3.8 | 4.5 | 3.1 | 3.4 | 3.6 | 3.8 | 3.9 | 4.2 | 4.1 | 3.9 | 3.7 |
Urea (mmol/L) | 32.52 | 29.8 | 16.42 | 4.55 | 4.77 | 4.46 | 4.13 | 3.8 | 4.17 | 3.74 | 4.02 |
Creatinine (μmol/L) | 89.73 | 85.64 | 64.59 | 43.78 | 58.44 | 53.76 | 49.19 | 46.52 | 27.26 | 24.54 | 30.45 |
PCT (ng/mL) | 5.73 | 3.86 | 11.5 | 5.1 | 1.86 | 2.65 | 2.58 | 2.45 | 2.18 | 3.65 | 4.53 |
- Citation: Xiao JJ, Ma JY, Liao J, Wu D, Lv C, Li HY, Zuo S, Zhu HT, Gu HJ. Fluorescence in situ hybridization-based confirmation of acute graft-vs-host disease diagnosis following liver transplantation: A case report. World J Gastrointest Surg 2021; 13(9): 1102-1109
- URL: https://www.wjgnet.com/1948-9366/full/v13/i9/1102.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v13.i9.1102